Regulation of TIMP-1 in Human Placenta and Fetal Membranes by lipopolysaccharide and demethylating agent 5-aza-2'-deoxycytidine

被引：0
|
作者：
Zoë L. Vincent
Murray D. Mitchell
Anna P. Ponnampalam
机构：
[1] Liggins Institute,
[2] University of Auckland,undefined
[3] Gravida: National Centre for Growth and Development,undefined
[4] University of Queensland Centre for Clinical Research,undefined
[5] The Heart Foundation,undefined
来源：
Reproductive Biology and Endocrinology | / 13卷
关键词：
TIMP1; Placenta; Labour; Epigenetics; Infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] EXPRESSION OF THE MAGE-1 TUMOR-ANTIGEN IS UP-REGULATED BY THE DEMETHYLATING AGENT 5-AZA-2'-DEOXYCYTIDINE
    WEBER, J
    SALGALLER, M
    SAMID, D
    JOHNSON, B
    HERLYN, M
    LASSAM, N
    TREISMAN, J
    ROSENBERG, SA
    CANCER RESEARCH, 1994, 54 (07) : 1766 - 1771
  • [22] TOXICOLOGY IN MICE OF THE ANTILEUKEMIC AGENT 5-AZA-2'-DEOXYCYTIDINE
    MOMPARLER, RL
    FRITH, CH
    DRUG AND CHEMICAL TOXICOLOGY, 1981, 4 (04) : 373 - 381
  • [23] Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2′-deoxycytidine
    Yuan, BZ
    Jefferson, AM
    Popescu, NC
    Reynolds, SH
    NEOPLASIA, 2004, 6 (04): : 412 - 419
  • [24] CELL-DEATH AND CELL-CYCLE PERTURBATION IN THE DEVELOPMENTAL TOXICITY OF THE DEMETHYLATING AGENT, 5-AZA-2'-DEOXYCYTIDINE
    ROGERS, JM
    FRANCIS, BM
    SULIK, KK
    ALLES, AJ
    MASSARO, EJ
    ZUCKER, RM
    ELSTEIN, KH
    ROSEN, MB
    CHERNOFF, N
    TERATOLOGY, 1994, 50 (05) : 332 - 339
  • [25] An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients
    P. W. Wijermans
    M. Lübbert
    G. Verhoef
    V. Klimek
    A. Bosly
    Annals of Hematology, 2005, 84 : 9 - 17
  • [26] Treatment with demethylating agent 5-Aza-2′-DeoxyCytidine (DAC) leads to enhanced sensitivity to Ionizing Radiation (IR) in colorectal carcinoma
    Forrer, C
    Hofstetter, B
    Pruschy, M
    Ciemik, IF
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S369 - S370
  • [27] Demethylating agent 5-aza-2′-deoxycytidine enhances expression of TNFRI and promotes TNF-mediated apoptosis in vitro and in vivo
    Kaminski, R
    Kozar, K
    Niderla, J
    Grzela, T
    Wilczynski, G
    Skierski, JS
    Koronkiewicz, M
    Jakobisiak, M
    Golab, J
    ONCOLOGY REPORTS, 2004, 12 (03) : 509 - 516
  • [28] An epigenetic approach to the treatment of advanced MDS;: the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients
    Wijermans, PW
    Lübbert, M
    Verhoef, G
    Klimek, V
    Bosly, A
    ANNALS OF HEMATOLOGY, 2005, 84 (Suppl 1) : 9 - 17
  • [29] 5-AZA-2'-DEOXYCYTIDINE, A NEW ANTI-LEUKEMIC AGENT
    MOMPARLER, RL
    GOODMAN, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 55 - 55
  • [30] Epigenetic regulation of the circadian clock: role of 5-aza-2′-deoxycytidine
    Tomita, Tatsunosuke
    Kurita, Ryoji
    Onishi, Yoshiaki
    BIOSCIENCE REPORTS, 2017, 37
12345